Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

NEW YORK, Aug. 17, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Koninklijke Philips N.V. ("Koninklijke" or the "Company") (NYSE: PHG) from February 25, 2020 through June 11, 2021 (the "Class Period").

PHG INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Koninklijke Philips N.V.

BENSALEM, Pa.--(BUSINESS WIRE)---- $PHG #CLASSACTION--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Koninklijke Philips N.V. (“Philips” or the “Company”) (NYSE: PHG) securities between February 25, 2020 and June 11, 2021, inclusive (the “Class Period”). Philips investors have until October 15, 2021 to file a lead plaintiff motion. Investors suffering losses on their Philips investments are encouraged to contact the Law Offices of Howard G. Sm

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Koninklijke Philips N.V.

NEW YORK, Aug. 16, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Koninklijke Philips N.V. ("Philips" or the "Company") (NYSE: PHG) and certain of its officers.

Pomerantz Law Firm Announces the Filing of a Class Action Against Koninklijke Philips N.V. and Certain Officers - PHG

Millions of Koninklijke Philips NV's (NYSE: PHG) CPAP machines and ventilators are under a recall posing severe health problems, as many people are having difficulties getting replacements. FDA handed down its Class I label, the most severe recall classification, for the recall.

Suffers' Lose Sleep After Philips' Recall Of Sleep Apnea Machine: WSJ

STAMFORD, Conn., Aug. 9, 2021 /PRNewswire/ -- In a first-of-its-kind partnership, Philips Sonicare, the #1 dental professional recommended power toothbrush brand worldwide, has collaborated with New York-based fashion and accessory brand, Susan Alexandra, to create a custom limited-edition travel accessory line highlighting self-expression through whimsical, bold designs.

Philips Sonicare Partners with Fashion Brand Susan Alexandra to Create an Exclusive Bold and Bright Travel Accessory Collection

Philips introduces new HealthSuite solutions to drive healthcare's digital transformation

Philips showcases integrated health informatics solutions across the care continuum during HIMSS21

Alcoa

BHP Billiton

ConocoPhillips

CoStar Group

KB Financial Group

Stellantis N.V. 

Constellation Brands

Twilio

Waste Connections

Healthy markets have made it hard to find stocks to buy that analysts have real conviction about. Here are 10 that make the cut.

The Top 10 Stocks to Buy According to Analysts

Philips Genomics Workspace enables integration of the largest-scale FDA-cleared cancer genetic test at NYU Langone Health

Koninklijke Philips N.V. (PHG) CEO Frans van Houten on Q2 2021 Results - Earnings Call Transcript

Philips led a downturn in European markets on Monday, as investors responded negatively to the Dutch conglomerate's outlook even as second-quarter earnings were a touch ahead of estimates.

Europe Markets: Philips shares tumble on fears over outlook as broader European stock markets slip

Koninklijke Philips NV (NYSE: PHG) reported second-quarter FY21 sales growth of 6% year-on-year to €4.23 billion. Comparable sales grew 9% Y/Y, representing double-digit growth in the Personal Health businesses and Diagnosis & Treatment businesses, partly offset by a double-digit decline in the Connected Care businesses.

Philips Reports Q2 Earnings, Posts Mixed Segment Results, Announces €1.5B Share Buyback

Dutch electronics giant Philips said Monday sales were up for the second quarter, but that profits took a hit from a recall of faulty sleep and respiratory care equipment.

Philips takes profit hit from product safety fault

Dutch health technology company Philips on Monday beat analysts' expectations with a jump in second-quarter core earnings to 532 million euros ($626 million), as the COVID-19 pandemic continued to spur demand for hospital equipment.

Philips second-quarter earnings beat forecast as pandemic fuels demand

Philips delivers Q2 sales of EUR 4.2 billion, with 9% comparable sales growth; net income amounts to EUR 153 million and Adjusted EBITA margin improves 280 basis points to 12.6%; company announces EUR 1.5 billion share buyback program

The FDA handed down its Class I label, the most severe recall classification, for Koninklijke Philips NV's (NYSE:PHG) ventilators for at-home and clinical use after the devices were found to put users at risk of inhaling or swallowing dangerous pieces of debris. Philips initiated the recall in mid-June.

FDA Gives 'Most Severe' Class I Label To Philips' Recall Of Faulty Ventilators, Sleep Apnea Machines

Philips receives FDA Breakthrough Device Designation for laser-assisted IVC filter removal device

Cognizant Technology Solutions

Philips (PHG) is collaborating with Cognizant to develop health solutions that will help healthcare and life science companies provide improved patient care and accelerate clinical trial procedure.

Philips (PHG)-Cognizant Collaborate to Develop Health Solutions

Alliance Pairs Cloud-Based Healthcare Platform with Experience-Oriented Application Design to Improve Patient Care and Clinical Trials Through Increased Provider-Patient Connectivity

Philips and Cognizant collaborate to introduce digital health solutions to providers, researchers, and patients

AMSTERDAM and TEANECK, N.J., July 8, 2021 /PRNewswire/ --  Royal Philips  (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Cognizant (Nasdaq: CTSH), a world-leading professional services firm, today announced a new collaboration to develop end-to-end digital health solutions that will enable healthcare organizations and life sciences companies to improve patient care and accelerate clinical trials.

Philips and Cognizant Collaborate to Introduce Digital Health Solutions to Providers, Researchers and Patients

Royal Philips (NYSE: PHG) announced a strategic partnership agreement with NICO.LAB, a MedTech stroke care company, significantly advancing Philips' commitment to improving outcomes for people who suffer a stroke. This partnership brings a cloud-based, end-to-end artificial intelligence (AI) based stroke triage and management solution, ‘StrokeViewer,' to improve patient outcomes by optimizing the stroke workflow.

Philips Accelerates Stroke Diagnosis And Treatment, Inks Strategic Partnership With MedTech NICO.LAB

Philips accelerates stroke diagnosis and treatment with expanded integrated solutions and strategic partnership

Philips announces first patient enrolled in the WE-TRUST global multicenter stroke study to assess the impact of the Direct to Angio Suite workflow in improving patient outcomes

BALA CYNWYD, Pa., July 6, 2021 /PRNewswire/ -- Connect America LLC, a nationally recognized innovator in digital health and connected care, announced it has finalized its acquisition of the Aging and Caregiving (ACG) business from Royal Philips (NYSE: PHG).

Connect America Completes Acquisition of Philips Aging and Caregiving Business

Stryker

PHG vs. SYK: Which Stock Is the Better Value Option?

PHG or SYK: Which Is the Better Value Stock Right Now?

News for Royal Philips Stock (PHG)